|
Real-time Estimate
Cboe BZX
12:34:07 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 84.23 USD | -4.92% |
|
-3.27% | +26.92% |
| Market Cap | 12.51B 10.78B 10.11B 9.23B 17.39B 1,196B 17.44B 120B 46.8B 604B 46.98B 45.96B 2,002B | P/E 2026 * |
-25x | P/E 2027 * | -19x |
|---|---|---|---|---|---|
| Enterprise Value | 11.68B 10.07B 9.44B 8.62B 16.23B 1,116B 16.28B 112B 43.69B 564B 43.86B 42.9B 1,869B | EV / Sales 2026 * |
25.3x | EV / Sales 2027 * | 34.9x |
| Free-Float |
94.56% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Arrowhead Pharmaceuticals, Inc.
| 1 day | -4.91% | ||
| 1 week | -3.27% | ||
| Current month | -0.46% | ||
| 1 month | -1.77% | ||
| 3 months | +6.59% | ||
| 6 months | +30.98% | ||
| Current year | +26.92% |
| 1 week | 84.21 |  | 90.21 |
| 1 month | 81.61 | | 90.97 |
| Current year | 54.02 | | 95.49 |
| 1 year | 21.61 | | 95.49 |
| 3 years | 9.57 | | 95.49 |
| 5 years | 9.57 | | 95.49 |
| 10 years | 1.2 | | 95.49 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 2007-11-30 | |
Daniel Apel
DFI | Director of Finance/CFO | - | 2025-05-12 |
Peter Carignan
CTO | Chief Tech/Sci/R&D Officer | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 56 | - | |
Mauro Ferrari
BRD | Director/Board Member | 66 | 2010-08-18 |
Michael Perry
BRD | Director/Board Member | 66 | 2011-12-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/18/26 | Sell | Director | -2,000 | 0.0014% | ||
| 8/18/26 | Sell | Director | -11,600 | 0.0082% | ||
| 6/15/26 | Free | Director | 11,882 | 0.0084% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.92% | -3.27% | +277.17% | +204.63% | 12.51B | |
| -1.59% | -6.25% | +64.99% | +99.09% | 70.64B | |
| -1.34% | -0.75% | +48.56% | +90.63% | 66.11B | |
| -7.72% | -11.23% | +1.52% | -14.25% | 27.98B | |
| -2.47% | -5.48% | -11.92% | +449.86% | 26.51B | |
| +0.30% | +2.03% | +59.48% | +14.21% | 26.44B | |
| -0.96% | +12.36% | +280.38% | +439.54% | 20.4B | |
| -0.51% | +0.23% | +33.71% | -18.02% | 20.17B | |
| -1.91% | -3.47% | +11.03% | +508.52% | 15.99B | |
| -1.76% | +0.54% | +43.46% | +145.13% | 13.69B | |
| Average | -2.26% | +1.13% | +80.84% | +191.93% | 30.04B | |
| Weighted average by Cap. | -2.05% | +1.23% | +65.70% | +153.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 463M 399M 374M 341M 643M 44.21B 645M 4.43B 1.73B 22.32B 1.74B 1.7B 74B | 339M 292M 274M 250M 472M 32.44B 473M 3.25B 1.27B 16.38B 1.27B 1.25B 54.3B |
| Net income | -504M -434M -407M -372M -700M -48.17B -703M -4.83B -1.89B -24.32B -1.89B -1.85B -80.63B | -655M -564M -529M -483M -910M -62.6B -913M -6.28B -2.45B -31.6B -2.46B -2.41B -105B |
| Net Debt | -832M -717M -672M -614M -1.16B -79.55B -1.16B -7.98B -3.11B -40.16B -3.13B -3.06B -133B | -683M -588M -552M -504M -949M -65.26B -952M -6.54B -2.55B -32.94B -2.56B -2.51B -109B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-28 | US$84.21 | -4.94% | 492,010 |
| 26-08-27 | US$88.59 | -0.59% | 857,522 |
| 26-08-26 | US$89.12 | +0.27% | 859,486 |
| 26-08-25 | US$88.88 | +2.48% | 983,042 |
| 26-08-24 | US$86.73 | -0.44% | 1,104,529 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARWR Stock
Select your edition
All financial news and data tailored to specific country editions
